View Single Post
Old 09-03-2006, 09:01 PM   #4
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
a vitamin A derivative is utilized to treat cutaneous T cell lymphoma in humans

I believe it is produced by Ligand Pharmaceuticals and is called targretin. It was explained to me that its effect was to cause the cancer cells to differentiate ie, stop multiplying and instead utillize the same energy for performing the normal appropriate functions for the cell--something all cancers could use!

It produced excellent results with someone I helped (by researching) with NKTcell lymphoma.

I read a paper out of MD Anderson(from several years ago) where they were looking into whether it might prevent breast cancer, but they did not seem to get good results and gave up on it it seems. if you want to research it look up breast cancer and targretin.
Lani is offline   Reply With Quote